Imunon (IMNN) Treasury Shares (2010 - 2026)
Imunon's (IMNN) quarterly Treasury Shares came in at $85188.0 in Q1 2026, little changed YoY from $85188.0 in Q1 2025, and little changed on a QoQ basis from $85188.0 in Q4 2025.
Imunon (IMNN) Treasury Shares (2010 - 2026) Analysis & Trends
Imunon (IMNN) has 17 years of Treasury Shares data on file, last reported at $85188.0 in Q1 2026.
- Quarterly Treasury Shares changed 0.0% year-over-year to $85188.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $85188.0 (changed 0.0% YoY) and the FY2025 annual result came in at $85188.0, changed 0.0% from the prior year.
- Treasury Shares steadied at $85188.0 in Q1 2026, from $85188.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $133333.0 in Q3 2025 to a low of $2.0 in Q4 2024.
- A 5-year average of $32543.5 and a median of $25000.0 in 2024 frame the typical range for Treasury Shares.
- The widest YoY moves for Treasury Shares: up 0.0% in 2022, down 0.0% in 2022.
- Tracing IMNN's Treasury Shares over 5 years: stood at $85188.0 in 2022, then changed by 0.0% to $85188.0 in 2023, then changed by 0.0% to $85188.0 in 2024, then changed by 0.0% to $85188.0 in 2025, then changed by 0.0% to $85188.0 in 2026.
- The last three Treasury Shares figures came in at $85188.0 (Q1 2026), $85188.0 (Q4 2025), and $85188.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 2.72 Mn |
| 10 | Imunon | 8.42 Mn | 8.42 Mn | - | 2.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.00 |
| Jun 30, 2026 | 2.00 |
| Mar 31, 2026 | 2.00 |
| Mar 31, 2026 | 2.00 |
| Mar 31, 2026 | 85,188.00 |
| Mar 31, 2026 | 85,188.00 |
| Dec 31, 2025 | 85,188.00 |
| Dec 31, 2025 | 85,188.00 |
| Dec 31, 2025 | 2.00 |
| Dec 31, 2025 | 2.00 |
| Sep 30, 2025 | 133,333.00 |
| Sep 30, 2025 | 85,188.00 |
| Sep 30, 2025 | 85,188.00 |
| Sep 30, 2025 | 133,333.00 |
| Jun 30, 2025 | 85,188.00 |
| Jun 30, 2025 | 1,667.00 |
| Jun 30, 2025 | 1,667.00 |
| Jun 30, 2025 | 85,188.00 |
| Mar 31, 2025 | 39,700.00 |
| Mar 31, 2025 | 85,188.00 |